Rangeley Capital, LLC Arbutus Biopharma Corp Transaction History
Rangeley Capital, LLC
- $111 Billion
- Q4 2024
A detailed history of Rangeley Capital, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Rangeley Capital, LLC holds 1,459,000 shares of ABUS stock, worth $4.84 Million. This represents 4.28% of its overall portfolio holdings.
Number of Shares
1,459,000Holding current value
$4.84 Million% of portfolio
4.28%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
165Shares Held
102MCall Options Held
2.15MPut Options Held
358K-
Morgan Stanley New York, NY21.7MShares$72.1 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$42.7 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.8 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$27.8 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $498M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...